HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemotherapy with cytosine arabinoside in a child with Burkitt's lymphoma on maintenance hemodialysis and hemofiltration.

Abstract
A case of Burkitt's lymphoma (stage IV) in an 8-year-old boy with end-stage renal failure due to hemolytic uremic syndrome is reported. The boy was treated by maintenance hemodialysis (HD) and hemofiltration (HF). During chemotherapy treatment with continuous cytosine arabinoside (Ara-C) infusion (100 mg/m2/d) for 7 days, concentrations of Ara-C and its metabolite uracil arabinoside (Ara-U) were measured in blood, dialysate, and filtrate. Ara-C levels were always below 200 ng/ml and were only qualitatively detectable in blood, dialysate, and filtrate. Ara-U levels were higher than 200 ng/ml after 18 h treatment and were measured quantitatively. Ara-U clearance during 3 h HD was 92 ml/min and the calculated mass removal 14.7 mg/3 h. In contrast, the Ara-U clearance during 3 h HF was 14 ml/min and the mass removal was 6.7 mg/3 h. Ara-C and Ara-U are eliminated by HD and HF in anuric patients. A continuous infusion of 100 mg Ara-C m2/d during HD or HF treatment did not result in a serum concentration above 200 ng/ml.
AuthorsJ M Pöschl, G Klaus, U Querfeld, R Ludwig, O Mehls
JournalAnnals of hematology (Ann Hematol) Vol. 67 Issue 1 Pg. 37-9 (Jul 1993) ISSN: 0939-5555 [Print] Germany
PMID8334197 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cytarabine
  • Arabinofuranosyluracil
Topics
  • Arabinofuranosyluracil (blood)
  • Burkitt Lymphoma (complications, drug therapy)
  • Child
  • Cytarabine (administration & dosage, blood, therapeutic use)
  • Hemofiltration
  • Humans
  • Infusions, Intravenous
  • Kidney Failure, Chronic (complications, therapy)
  • Male
  • Renal Dialysis
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: